Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
暂无分享,去创建一个
[1] I. Kramer,et al. Histological Typing of Odontogenic Tumours , 1992, World Health Organization.
[2] S. Knuutila,et al. Gene Expression Profiling of Ameloblastoma and Human Tooth Germ by Means of a cDNA Microarray , 2002, Journal of dental research.
[3] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[4] T. Mak,et al. Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.
[5] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[6] K. Kindaichi. An electron microscopic study of cell death in molar tooth germ epithelia of mouse embryos. , 1980, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.
[7] Keisuke Kuida,et al. Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.
[8] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[9] José Luis de la Pompa,et al. Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.
[10] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[11] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[12] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[13] Francesco Cecconi,et al. Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.
[14] V. Dawson,et al. Role of AIF in caspase-dependent and caspase-independent cell death , 2004, Oncogene.
[15] N. Nakamura,et al. Two relatively distinct patterns of ameloblastoma: an anti‐apoptotic proliferating site in the outer layer (periphery) and a pro‐apoptotic differentiating site in the inner layer (centre) , 2001, Histopathology.
[16] S. Agrawal,et al. Survivin inhibition induces human neural tumor cell death through caspase‐independent and ‐dependent pathways , 2001, Journal of neurochemistry.
[17] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[18] T. Mak,et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.
[19] H. Kumamoto. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[20] S. Knuutila,et al. Cell proliferation and chromosomal changes in human ameloblastoma. , 2002, Cancer genetics and cytogenetics.
[21] R. Lock,et al. The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma. , 2001, European journal of cancer.
[22] J. Liu,et al. Apoptosome dysfunction in human cancer , 2004, Apoptosis.
[23] P. Slootweg,et al. Immunohistochemical demonstration of bcl-2 protein in human tooth germs. , 1994, Archives of oral biology.
[24] J. Sciubba. Tumors and cysts of the jaws , 2001 .
[25] L. Jia,et al. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia , 2003, Oncogene.
[26] H. Kumamoto,et al. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[27] H. Kumamoto,et al. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[28] L. R. Eversole. Malignant epithelial odontogenic tumors. , 1999, Seminars in diagnostic pathology.
[29] H. Kumamoto,et al. Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas , 2004, Virchows Archiv.
[30] M. Raff,et al. Programmed Cell Death in Animal Development , 1997, Cell.
[31] H. Kumamoto,et al. Immunohistochemical analysis of bcl‐2 family proteins in benign and malignant ameloblastomas , 2007 .
[32] A. Vaahtokari,et al. Apoptosis in the developing tooth: association with an embryonic signaling center and suppression by EGF and FGF-4. , 1996, Development.
[33] R. Melrose. Benign epithelial odontogenic tumors. , 1999, Seminars in diagnostic pathology.
[34] G. Mills,et al. Defective Cytochrome c-dependent Caspase Activation in Ovarian Cancer Cell Lines due to Diminished or Absent Apoptotic Protease Activating Factor-1 Activity* , 2001, The Journal of Biological Chemistry.
[35] H. Kumamoto,et al. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[36] G. Kroemer,et al. Involvement of apoptosis‐inducing factor during dolichyl monophosphate‐induced apoptosis in U937 cells , 2000, FEBS letters.
[37] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.